

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.26889335 |
| 2 | DNA deamination (GO:0045006) | 6.05963708 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.80389583 |
| 4 | viral transcription (GO:0019083) | 5.37283277 |
| 5 | translational termination (GO:0006415) | 5.17286312 |
| 6 | cytidine metabolic process (GO:0046087) | 5.01580926 |
| 7 | cytidine catabolic process (GO:0006216) | 5.01580926 |
| 8 | cytidine deamination (GO:0009972) | 5.01580926 |
| 9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.72743385 |
| 10 | protein targeting to ER (GO:0045047) | 4.67409579 |
| 11 | cotranslational protein targeting to membrane (GO:0006613) | 4.67374876 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.65536442 |
| 13 | translational elongation (GO:0006414) | 4.58630405 |
| 14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.50785180 |
| 15 | protein localization to endoplasmic reticulum (GO:0070972) | 4.40183424 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 4.27171982 |
| 17 | negative regulation by host of viral transcription (GO:0043922) | 4.11434938 |
| 18 | ATP synthesis coupled proton transport (GO:0015986) | 4.07708270 |
| 19 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.07708270 |
| 20 | positive regulation of prostaglandin secretion (GO:0032308) | 4.03232190 |
| 21 | ribosomal small subunit biogenesis (GO:0042274) | 3.96861359 |
| 22 | cellular protein complex disassembly (GO:0043624) | 3.91140486 |
| 23 | viral life cycle (GO:0019058) | 3.90158764 |
| 24 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.78707856 |
| 25 | behavioral response to nicotine (GO:0035095) | 3.77788215 |
| 26 | protein neddylation (GO:0045116) | 3.76737605 |
| 27 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.71037146 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.70828722 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 3.62877413 |
| 30 | mannosylation (GO:0097502) | 3.62427911 |
| 31 | activated T cell proliferation (GO:0050798) | 3.56990622 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 3.49105307 |
| 33 | translational initiation (GO:0006413) | 3.43198562 |
| 34 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.41697344 |
| 35 | negative regulation of telomere maintenance (GO:0032205) | 3.39827656 |
| 36 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.35101095 |
| 37 | positive regulation of defense response to virus by host (GO:0002230) | 3.32589307 |
| 38 | respiratory electron transport chain (GO:0022904) | 3.29822091 |
| 39 | electron transport chain (GO:0022900) | 3.28561887 |
| 40 | T cell migration (GO:0072678) | 3.27933522 |
| 41 | negative regulation of T cell apoptotic process (GO:0070233) | 3.20037022 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.20015842 |
| 43 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.19327361 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14863212 |
| 45 | protein complex disassembly (GO:0043241) | 3.14112583 |
| 46 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.12986680 |
| 47 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.12878467 |
| 48 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.11060306 |
| 49 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.10971176 |
| 50 | sequestering of actin monomers (GO:0042989) | 3.08055095 |
| 51 | translation (GO:0006412) | 3.07588351 |
| 52 | macromolecular complex disassembly (GO:0032984) | 3.06870615 |
| 53 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.06613214 |
| 54 | regulation of immunoglobulin secretion (GO:0051023) | 3.00431297 |
| 55 | positive regulation of fatty acid transport (GO:2000193) | 2.97514452 |
| 56 | proteasome assembly (GO:0043248) | 2.91677523 |
| 57 | protein targeting to membrane (GO:0006612) | 2.91592976 |
| 58 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.91215922 |
| 59 | regulation of prostaglandin secretion (GO:0032306) | 2.90701209 |
| 60 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.88730449 |
| 61 | metallo-sulfur cluster assembly (GO:0031163) | 2.87318743 |
| 62 | iron-sulfur cluster assembly (GO:0016226) | 2.87318743 |
| 63 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86464475 |
| 64 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.86229443 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.84761701 |
| 66 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.83057515 |
| 67 | positive regulation of cell killing (GO:0031343) | 2.81173720 |
| 68 | hydrogen ion transmembrane transport (GO:1902600) | 2.80767179 |
| 69 | mRNA catabolic process (GO:0006402) | 2.79921366 |
| 70 | positive regulation of icosanoid secretion (GO:0032305) | 2.78555391 |
| 71 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.78408654 |
| 72 | actin nucleation (GO:0045010) | 2.78244106 |
| 73 | protein-cofactor linkage (GO:0018065) | 2.77814327 |
| 74 | peptidyl-histidine modification (GO:0018202) | 2.74209071 |
| 75 | cytolysis (GO:0019835) | 2.72654136 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.72393633 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 2.72393633 |
| 78 | proton transport (GO:0015992) | 2.70008553 |
| 79 | negative T cell selection (GO:0043383) | 2.69258429 |
| 80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.68774535 |
| 81 | protein complex biogenesis (GO:0070271) | 2.67355305 |
| 82 | positive regulation of T cell cytokine production (GO:0002726) | 2.67204139 |
| 83 | sulfation (GO:0051923) | 2.65823552 |
| 84 | GPI anchor metabolic process (GO:0006505) | 2.65638258 |
| 85 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.64296219 |
| 86 | hydrogen transport (GO:0006818) | 2.63469295 |
| 87 | GPI anchor biosynthetic process (GO:0006506) | 2.63373062 |
| 88 | chaperone-mediated protein transport (GO:0072321) | 2.62332140 |
| 89 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.61348023 |
| 90 | ribosomal large subunit biogenesis (GO:0042273) | 2.61267851 |
| 91 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.60841863 |
| 92 | regulation of meiosis I (GO:0060631) | 2.59249035 |
| 93 | response to interleukin-15 (GO:0070672) | 2.58433003 |
| 94 | indolalkylamine metabolic process (GO:0006586) | 2.58376063 |
| 95 | negative thymic T cell selection (GO:0045060) | 2.57367821 |
| 96 | endoderm formation (GO:0001706) | 2.55498815 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54357561 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.54119643 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 2.51770594 |
| 100 | cellular ketone body metabolic process (GO:0046950) | 2.49292868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.63203042 |
| 2 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.69822027 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.59036928 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.54493167 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.29588994 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27061055 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81686765 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.80139726 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77080215 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.69574587 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66569516 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.64789551 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.42403671 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.35309219 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.30011427 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.19619333 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.17996664 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.14963534 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02055735 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.00492662 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83724055 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79735805 |
| 23 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.76619764 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.67234398 |
| 25 | GATA3_26560356_Chip-Seq_TH2_Human | 1.57032773 |
| 26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.56554887 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55545565 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52673219 |
| 29 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.49438914 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48773017 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47272326 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45155629 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44990355 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.43586600 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42857009 |
| 36 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.42437501 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.41770544 |
| 38 | AR_20517297_ChIP-Seq_VCAP_Human | 1.37371732 |
| 39 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.36858824 |
| 40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35829488 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33682149 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31148598 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27633641 |
| 44 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.27170376 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26783300 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24732192 |
| 47 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.24658328 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23525428 |
| 49 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23525428 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22722618 |
| 51 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.20330200 |
| 52 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17828008 |
| 53 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.16936807 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16571788 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15580421 |
| 56 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15309802 |
| 57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.15297491 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14827339 |
| 59 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13973431 |
| 60 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.13536167 |
| 61 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.13001744 |
| 62 | ERA_21632823_ChIP-Seq_H3396_Human | 1.11849632 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11615057 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.09525320 |
| 65 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08760210 |
| 66 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05664571 |
| 67 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04072288 |
| 68 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.03090857 |
| 69 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02629331 |
| 70 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01680423 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01482406 |
| 72 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00731312 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98449367 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98348020 |
| 75 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97238041 |
| 76 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.95908819 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 0.95857324 |
| 78 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95565421 |
| 79 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95396399 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93899280 |
| 81 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.93831537 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93074019 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93067388 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93029768 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93003131 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92755690 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.91653476 |
| 88 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.90037562 |
| 89 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89717267 |
| 90 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89121515 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.88804232 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88201621 |
| 93 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87767905 |
| 94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86686368 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.85884563 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85715150 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84294551 |
| 98 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.83205362 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83037006 |
| 100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83037006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.79716748 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.50648412 |
| 3 | MP0002277_abnormal_respiratory_mucosa | 2.94478852 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.90962098 |
| 5 | MP0003011_delayed_dark_adaptation | 2.53151960 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.32569259 |
| 7 | MP0009785_altered_susceptibility_to | 2.19974054 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.14426451 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.04737515 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.04387026 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.00546703 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 1.89877882 |
| 13 | MP0006292_abnormal_olfactory_placode | 1.86289984 |
| 14 | MP0000685_abnormal_immune_system | 1.81387151 |
| 15 | MP0004742_abnormal_vestibular_system | 1.80548375 |
| 16 | MP0002736_abnormal_nociception_after | 1.79333684 |
| 17 | MP0001968_abnormal_touch/_nociception | 1.78495559 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 1.72903174 |
| 19 | MP0002653_abnormal_ependyma_morphology | 1.66556855 |
| 20 | MP0002095_abnormal_skin_pigmentation | 1.65622367 |
| 21 | MP0008877_abnormal_DNA_methylation | 1.64399491 |
| 22 | MP0001800_abnormal_humoral_immune | 1.64115062 |
| 23 | MP0003436_decreased_susceptibility_to | 1.63151050 |
| 24 | MP0000566_synostosis | 1.62660482 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.62089570 |
| 26 | MP0006072_abnormal_retinal_apoptosis | 1.55245412 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.54435901 |
| 28 | MP0003724_increased_susceptibility_to | 1.53122381 |
| 29 | MP0003878_abnormal_ear_physiology | 1.44002892 |
| 30 | MP0005377_hearing/vestibular/ear_phenot | 1.44002892 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.43760612 |
| 32 | MP0001790_abnormal_immune_system | 1.42758522 |
| 33 | MP0005387_immune_system_phenotype | 1.42758522 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.40826713 |
| 35 | MP0002723_abnormal_immune_serum | 1.40028977 |
| 36 | MP0001819_abnormal_immune_cell | 1.38015904 |
| 37 | MP0003866_abnormal_defecation | 1.37507156 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.36046426 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35393143 |
| 40 | MP0000613_abnormal_salivary_gland | 1.32293064 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.31478135 |
| 42 | MP0004885_abnormal_endolymph | 1.29682589 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.27358430 |
| 44 | MP0002938_white_spotting | 1.26918822 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.25707134 |
| 46 | MP0008872_abnormal_physiological_respon | 1.20553316 |
| 47 | MP0003880_abnormal_central_pattern | 1.19701322 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.18597649 |
| 49 | MP0003195_calcinosis | 1.18448552 |
| 50 | MP0005025_abnormal_response_to | 1.16761842 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.16469057 |
| 52 | MP0001905_abnormal_dopamine_level | 1.15858416 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.13612605 |
| 54 | MP0001984_abnormal_olfaction | 1.13499785 |
| 55 | MP0002282_abnormal_trachea_morphology | 1.13179973 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.12178338 |
| 57 | MP0001873_stomach_inflammation | 1.10729408 |
| 58 | MP0008995_early_reproductive_senescence | 1.10617779 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.10552366 |
| 60 | MP0000631_abnormal_neuroendocrine_gland | 1.09668461 |
| 61 | MP0002405_respiratory_system_inflammati | 1.09022480 |
| 62 | MP0005253_abnormal_eye_physiology | 1.00076106 |
| 63 | MP0003136_yellow_coat_color | 0.99650224 |
| 64 | MP0003045_fibrosis | 0.98462220 |
| 65 | MP0004147_increased_porphyrin_level | 0.98340755 |
| 66 | MP0000716_abnormal_immune_system | 0.98226322 |
| 67 | MP0001881_abnormal_mammary_gland | 0.96368237 |
| 68 | MP0001485_abnormal_pinna_reflex | 0.95927453 |
| 69 | MP0009745_abnormal_behavioral_response | 0.94158618 |
| 70 | MP0001346_abnormal_lacrimal_gland | 0.91215500 |
| 71 | MP0001188_hyperpigmentation | 0.90068627 |
| 72 | MP0002102_abnormal_ear_morphology | 0.89412989 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.87394033 |
| 74 | MP0003787_abnormal_imprinting | 0.87181451 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.85057337 |
| 76 | MP0002163_abnormal_gland_morphology | 0.84143842 |
| 77 | MP0002398_abnormal_bone_marrow | 0.84093396 |
| 78 | MP0009764_decreased_sensitivity_to | 0.83761497 |
| 79 | MP0000647_abnormal_sebaceous_gland | 0.83748502 |
| 80 | MP0001764_abnormal_homeostasis | 0.83541791 |
| 81 | MP0005084_abnormal_gallbladder_morpholo | 0.82789739 |
| 82 | MP0002272_abnormal_nervous_system | 0.80799384 |
| 83 | MP0001529_abnormal_vocalization | 0.79698406 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.79525105 |
| 85 | MP0008058_abnormal_DNA_repair | 0.79267706 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.79246155 |
| 87 | MP0010155_abnormal_intestine_physiology | 0.79157016 |
| 88 | MP0000049_abnormal_middle_ear | 0.78531459 |
| 89 | MP0003786_premature_aging | 0.77763298 |
| 90 | MP0003938_abnormal_ear_development | 0.76816523 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.76013967 |
| 92 | MP0004381_abnormal_hair_follicle | 0.75640482 |
| 93 | MP0001533_abnormal_skeleton_physiology | 0.75021937 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.74595873 |
| 95 | MP0005410_abnormal_fertilization | 0.74218410 |
| 96 | MP0001919_abnormal_reproductive_system | 0.73586667 |
| 97 | MP0005389_reproductive_system_phenotype | 0.69802039 |
| 98 | MP0002928_abnormal_bile_duct | 0.69791716 |
| 99 | MP0000689_abnormal_spleen_morphology | 0.68966743 |
| 100 | MP0003936_abnormal_reproductive_system | 0.68955927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type II lissencephaly (HP:0007260) | 4.19867206 |
| 2 | Aplastic anemia (HP:0001915) | 3.87885808 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.86285594 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.63006661 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.47526259 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43386584 |
| 7 | IgG deficiency (HP:0004315) | 3.37265148 |
| 8 | Reticulocytopenia (HP:0001896) | 3.16022909 |
| 9 | T lymphocytopenia (HP:0005403) | 3.15188148 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.11395019 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 3.05935933 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.04890947 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.01789721 |
| 14 | Septo-optic dysplasia (HP:0100842) | 3.01641243 |
| 15 | Concave nail (HP:0001598) | 2.99314191 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.97140678 |
| 17 | Acute encephalopathy (HP:0006846) | 2.93214528 |
| 18 | Cerebellar dysplasia (HP:0007033) | 2.91909725 |
| 19 | 3-Methylglutaconic aciduria (HP:0003535) | 2.89952896 |
| 20 | Increased CSF lactate (HP:0002490) | 2.89855234 |
| 21 | Abnormality of T cell number (HP:0011839) | 2.83499014 |
| 22 | Retinal dysplasia (HP:0007973) | 2.81472949 |
| 23 | Abnormal number of erythroid precursors (HP:0012131) | 2.75601809 |
| 24 | Congenital, generalized hypertrichosis (HP:0004540) | 2.75310996 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.74357705 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.66127433 |
| 27 | Macrocytic anemia (HP:0001972) | 2.60840398 |
| 28 | Abolished electroretinogram (ERG) (HP:0000550) | 2.56512766 |
| 29 | Pancreatic fibrosis (HP:0100732) | 2.54490081 |
| 30 | Pancreatic cysts (HP:0001737) | 2.54018184 |
| 31 | Abnormality of T cells (HP:0002843) | 2.53914734 |
| 32 | Pancytopenia (HP:0001876) | 2.53536342 |
| 33 | Colon cancer (HP:0003003) | 2.51011454 |
| 34 | Renal Fanconi syndrome (HP:0001994) | 2.48396289 |
| 35 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47917327 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 2.44670575 |
| 37 | Molar tooth sign on MRI (HP:0002419) | 2.44670575 |
| 38 | Hepatocellular necrosis (HP:0001404) | 2.44283472 |
| 39 | Hypoproteinemia (HP:0003075) | 2.43950401 |
| 40 | Cerebral edema (HP:0002181) | 2.43535869 |
| 41 | Thyroiditis (HP:0100646) | 2.39415885 |
| 42 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.37755206 |
| 43 | Nephronophthisis (HP:0000090) | 2.37526275 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.37133382 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36510803 |
| 46 | Renal cortical cysts (HP:0000803) | 2.34831929 |
| 47 | Optic disc pallor (HP:0000543) | 2.33552447 |
| 48 | Recurrent bronchitis (HP:0002837) | 2.30113693 |
| 49 | Testicular atrophy (HP:0000029) | 2.27548155 |
| 50 | Hypoplasia of the pons (HP:0012110) | 2.27445872 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23988133 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23988133 |
| 53 | Humeroradial synostosis (HP:0003041) | 2.23603682 |
| 54 | Synostosis involving the elbow (HP:0003938) | 2.23603682 |
| 55 | Combined immunodeficiency (HP:0005387) | 2.23143390 |
| 56 | Lissencephaly (HP:0001339) | 2.22050708 |
| 57 | Hepatic necrosis (HP:0002605) | 2.21777655 |
| 58 | True hermaphroditism (HP:0010459) | 2.19573041 |
| 59 | Stomatitis (HP:0010280) | 2.18705481 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.16294816 |
| 61 | Abnormality of the pons (HP:0007361) | 2.16134628 |
| 62 | Visual hallucinations (HP:0002367) | 2.14673700 |
| 63 | Methylmalonic acidemia (HP:0002912) | 2.14343344 |
| 64 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08397845 |
| 65 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08397845 |
| 66 | Rib fusion (HP:0000902) | 2.07475664 |
| 67 | Prostate neoplasm (HP:0100787) | 2.02475185 |
| 68 | Lipid accumulation in hepatocytes (HP:0006561) | 1.98674448 |
| 69 | Abnormality of the renal medulla (HP:0100957) | 1.97840428 |
| 70 | Abnormality of eosinophils (HP:0001879) | 1.97376484 |
| 71 | Pallor (HP:0000980) | 1.94466043 |
| 72 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.92973432 |
| 73 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.92076920 |
| 74 | Increased serum lactate (HP:0002151) | 1.91615214 |
| 75 | Infantile muscular hypotonia (HP:0008947) | 1.91597220 |
| 76 | Flat capital femoral epiphysis (HP:0003370) | 1.91408696 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 1.90750446 |
| 78 | Hyperalaninemia (HP:0003348) | 1.90750446 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90750446 |
| 80 | Lactic acidosis (HP:0003128) | 1.89857248 |
| 81 | Maternal diabetes (HP:0009800) | 1.89199778 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 1.88784112 |
| 83 | Lethargy (HP:0001254) | 1.88339322 |
| 84 | Chronic hepatic failure (HP:0100626) | 1.88129779 |
| 85 | Lymphopenia (HP:0001888) | 1.87679485 |
| 86 | Bronchitis (HP:0012387) | 1.87085835 |
| 87 | Tubular atrophy (HP:0000092) | 1.84925399 |
| 88 | Parakeratosis (HP:0001036) | 1.83126395 |
| 89 | Dyschromatopsia (HP:0007641) | 1.81801870 |
| 90 | Optic nerve hypoplasia (HP:0000609) | 1.78334361 |
| 91 | B lymphocytopenia (HP:0010976) | 1.77420902 |
| 92 | Methylmalonic aciduria (HP:0012120) | 1.77188423 |
| 93 | Conical tooth (HP:0000698) | 1.76643987 |
| 94 | Absent septum pellucidum (HP:0001331) | 1.76492897 |
| 95 | Opisthotonus (HP:0002179) | 1.76220347 |
| 96 | Absent thumb (HP:0009777) | 1.76158616 |
| 97 | Increased muscle lipid content (HP:0009058) | 1.76106284 |
| 98 | Severe muscular hypotonia (HP:0006829) | 1.76005051 |
| 99 | Bile duct proliferation (HP:0001408) | 1.75739635 |
| 100 | Abnormal biliary tract physiology (HP:0012439) | 1.75739635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.98516361 |
| 2 | TESK2 | 4.68778868 |
| 3 | MAP4K2 | 3.96958798 |
| 4 | BCKDK | 2.84373623 |
| 5 | MAP4K1 | 2.79350431 |
| 6 | ZAK | 2.78559433 |
| 7 | TLK1 | 2.74953584 |
| 8 | KDR | 2.74513667 |
| 9 | VRK2 | 2.73995915 |
| 10 | MUSK | 2.59980895 |
| 11 | ADRBK2 | 2.42211300 |
| 12 | TESK1 | 2.00969297 |
| 13 | VRK1 | 1.96372770 |
| 14 | PNCK | 1.91963498 |
| 15 | GRK1 | 1.82030634 |
| 16 | ITK | 1.68176175 |
| 17 | IKBKE | 1.64213607 |
| 18 | WNK3 | 1.46325446 |
| 19 | CAMKK2 | 1.44397626 |
| 20 | WNK4 | 1.43974275 |
| 21 | LRRK2 | 1.39793097 |
| 22 | NUAK1 | 1.37283925 |
| 23 | TNK2 | 1.34159010 |
| 24 | GRK6 | 1.28983816 |
| 25 | IKBKB | 1.21531903 |
| 26 | LIMK1 | 1.18912875 |
| 27 | PIK3CA | 1.14682903 |
| 28 | PRKCQ | 1.14670119 |
| 29 | IRAK4 | 1.14040744 |
| 30 | PINK1 | 1.13684766 |
| 31 | FES | 1.11187888 |
| 32 | TBK1 | 1.03570615 |
| 33 | AKT3 | 1.01861068 |
| 34 | MAP3K4 | 1.01671635 |
| 35 | DYRK2 | 0.99851586 |
| 36 | MAP2K6 | 0.99575715 |
| 37 | PASK | 0.99347977 |
| 38 | BTK | 0.97791484 |
| 39 | TIE1 | 0.96841734 |
| 40 | TEC | 0.93608389 |
| 41 | STK39 | 0.91802338 |
| 42 | ADRBK1 | 0.91347741 |
| 43 | PAK3 | 0.90217121 |
| 44 | CDK8 | 0.86777849 |
| 45 | MAPKAPK3 | 0.85747565 |
| 46 | NME1 | 0.84892729 |
| 47 | PIK3CG | 0.84347503 |
| 48 | MST4 | 0.83884873 |
| 49 | IRAK2 | 0.83537424 |
| 50 | WEE1 | 0.80431364 |
| 51 | SYK | 0.79945251 |
| 52 | MAP2K7 | 0.78725648 |
| 53 | MAP3K11 | 0.77562121 |
| 54 | LCK | 0.76416939 |
| 55 | CSK | 0.76229522 |
| 56 | SIK2 | 0.74154449 |
| 57 | BUB1 | 0.73348068 |
| 58 | INSRR | 0.67960891 |
| 59 | MAP2K2 | 0.66288785 |
| 60 | MAPK13 | 0.65260915 |
| 61 | CDK19 | 0.64270862 |
| 62 | EPHB2 | 0.64063986 |
| 63 | LYN | 0.60309155 |
| 64 | PDK2 | 0.59834325 |
| 65 | NME2 | 0.59387737 |
| 66 | GRK7 | 0.57488597 |
| 67 | FRK | 0.57165665 |
| 68 | CAMK1 | 0.54818623 |
| 69 | BMPR2 | 0.50288552 |
| 70 | IGF1R | 0.50196832 |
| 71 | AURKA | 0.48136857 |
| 72 | CSNK2A2 | 0.45741400 |
| 73 | BRSK2 | 0.43483697 |
| 74 | NTRK2 | 0.42443494 |
| 75 | KIT | 0.42079759 |
| 76 | PRKACA | 0.41543550 |
| 77 | PRKCG | 0.41364503 |
| 78 | MAPK15 | 0.39620850 |
| 79 | STK16 | 0.37539295 |
| 80 | PLK4 | 0.36601338 |
| 81 | TAOK3 | 0.35675735 |
| 82 | OBSCN | 0.35099114 |
| 83 | BRSK1 | 0.34946254 |
| 84 | PIM1 | 0.34892350 |
| 85 | MAP3K12 | 0.34534295 |
| 86 | CHUK | 0.33052196 |
| 87 | CSNK2A1 | 0.32579144 |
| 88 | CSNK1A1 | 0.32568577 |
| 89 | CAMK2A | 0.32478072 |
| 90 | RPS6KA5 | 0.32038220 |
| 91 | PRKCA | 0.30481118 |
| 92 | TRIM28 | 0.30206623 |
| 93 | CAMKK1 | 0.28470535 |
| 94 | OXSR1 | 0.28016495 |
| 95 | MAP3K14 | 0.26603337 |
| 96 | ATR | 0.25054735 |
| 97 | AURKB | 0.23402036 |
| 98 | CSNK1E | 0.22526862 |
| 99 | SRPK1 | 0.22414641 |
| 100 | EIF2AK2 | 0.21978505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.64021294 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.01296486 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.85753728 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.19691266 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.03298914 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.58532636 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.18025104 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.14485560 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.13685211 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.11795580 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.10791048 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.08628308 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 1.92156343 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.87418172 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86768795 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.82227286 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.75082170 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72827202 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68966928 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64379104 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.60682351 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39680429 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39416746 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39189418 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.39131531 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.35370153 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32588525 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31718132 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31227925 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30321293 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28111038 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27212473 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26974157 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.25446397 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24510240 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24234380 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22573983 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20903889 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18562628 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16603436 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14818687 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13603955 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12663815 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09799641 |
| 45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09416609 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 1.05469938 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.04558051 |
| 48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02873992 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99245657 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94720148 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94180248 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93722051 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91814206 |
| 54 | Purine metabolism_Homo sapiens_hsa00230 | 0.89286285 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.87918753 |
| 56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84723132 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83387809 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.74538504 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72845312 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68256870 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67190892 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63809582 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60252202 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59095701 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58579368 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56547494 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56329496 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56131894 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55930837 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53462948 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.52112768 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51193056 |
| 73 | Spliceosome_Homo sapiens_hsa03040 | 0.50542826 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.47938491 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46950299 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46217640 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.45188890 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44641869 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44034443 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43886026 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42756040 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42423931 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41683168 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41480483 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38661101 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34909157 |
| 87 | DNA replication_Homo sapiens_hsa03030 | 0.33640157 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30367378 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29784517 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29751760 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29316243 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29135513 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.28675386 |
| 94 | RNA transport_Homo sapiens_hsa03013 | 0.28248638 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26147005 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.24921424 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.24753332 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23118035 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.20921495 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.17893044 |

